Axsome Therapeutics
Developer of CNS medicines for depression, Alzheimer’s agitation, daytime sleepiness, and migraine.
$199.00
After-hours close−0.07 (−0.04%)
At close$199.07(−3.49%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.54 | — | — |
| Aug 2026 | −$0.89 | −$0.99 | −11.0% |
| May 2026 | −$0.85 | −$1.26 | −48.2% |
| Feb 2026 | −$0.70 | −$0.71 | −1.4% |
| Nov 2025 | −$0.82 | −$0.94 | −14.6% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Sep 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 2, 2026 | −$0.54 | — | — | $258.3M | — | — |
| Aug 10, 2026 | −$0.89 | −$0.99 | −11.0% | $221.1M | $216.4M | −2.2% |
| May 4, 2026 | −$0.85 | −$1.26 | −48.2% | $190.9M | $189.4M | −0.8% |
| Feb 23, 2026 | −$0.70 | −$0.71 | −1.4% | $193.4M | $194.7M | +0.7% |
| Nov 3, 2025 | −$0.82 | −$0.94 | −14.6% | $191.3M | $171.0M | −10.6% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 4, 2025 | ||||||
| May 5, 2025 | ||||||
| Feb 18, 2025 | ||||||
| Nov 12, 2024 | ||||||
| Aug 5, 2024 | ||||||
| May 6, 2024 | ||||||
| Feb 20, 2024 | ||||||
| Nov 6, 2023 | ||||||
| Aug 7, 2023 | ||||||
| May 8, 2023 | ||||||
| Feb 27, 2023 | ||||||
| Nov 7, 2022 | ||||||
| Aug 9, 2022 | ||||||
| May 2, 2022 | ||||||
| Mar 1, 2022 | ||||||
| Nov 8, 2021 | ||||||
| Aug 9, 2021 | ||||||
| May 10, 2021 | ||||||
| Mar 1, 2021 | ||||||
| Nov 5, 2020 | ||||||
| Aug 10, 2020 | ||||||
| May 8, 2020 | ||||||
| Mar 12, 2020 | ||||||
| Nov 7, 2019 | ||||||
| Aug 8, 2019 | ||||||
| May 9, 2019 | ||||||
| Mar 14, 2019 | ||||||
| Nov 9, 2018 | ||||||
| Aug 8, 2018 | ||||||
| May 8, 2018 | ||||||
| Mar 7, 2018 | ||||||
| Nov 8, 2017 | ||||||
| Aug 9, 2017 | ||||||
| May 9, 2017 | ||||||
| Mar 7, 2017 | ||||||
| Nov 14, 2016 | ||||||
| Aug 9, 2016 | ||||||
| May 11, 2016 | ||||||
| Mar 24, 2016 | ||||||
| Nov 24, 2015 | ||||||
| Sep 30, 2015 | ||||||